In order to study predisposition to high IgA response in AS and yersinia arthritis we measured the in-vitro immunoglobulin (Ig) production in patients with AS and in persons who have once had yersinia arthritis. B-lymphocyte activation by yersinia was also studied. AS patients with mild subjective symtoms were chosen in order to avoid possible effects of in-vivo generated inflammatory factors on lymphocyte functions.
SUMMARY In ankylosing spondylitis (AS) and in yersinia arthritis the main findings in serum immunoglobulin (Ig) studies have been raised IgA in AS and a high anti-yersinia IgA and IgG response and the persistence of IgA class antibodies in yersinia arthritis. In order to study predisposition to high IgA response in AS and yersinia arthritis we measured the in-vitro Ig production in patients with AS and in persons who have once had yersinia arthritis, and we compared it with the Ig production in persons who have had yersiniosis but recovered without getting arthritis and with that in healthy controls. IgA secretion by peripheral blood lymphocytes stimulated by pokeweed mitogen was the same in all 4 groups, and no signs of higher IgA production in AS patients could be found. In AS patients lymphocyte activation by whole yersinia bacteria resulted in higher total IgG production than in healthy controls. The total number of plaque-forming cells in yersinia-stimulated cultures was significantly higher in persons who have had yersiniosis without arthritis than in persons who have suffered from yersinia arthritis or in persons in other groups. AS patients had low IgM production, which reverted to normal when hydrocortisone was added to the culture. The in-vitro Ig production in general did not correlate with the presence of the HLA B27 antigen but rather with the clinical history of the subjects studied.
There is evidence that gastrointestinal infection may be an important aetiological factor in ankylosing spondylitis (AS). Sacroiliitis and AS are common sequelae in persons who develop arthritis after intestinal infection with salmonella, shigella, or Yersinia enterocolitica.' Raised levels of serum Statistical analysis. The statistical significance of the differences in the Ig production between the 4 groups was evaluated by Mann-Whitney U-test.
Results
The number of Ig producing cells was measured by a reverse PFC assay and the secretion of IgA, IgG, and IgM by measuring the amount of these immunoglobulins in the culture supernatant. There was a tendency towards high PFC numbers in persons who had had yersiniosis without arthritis and towards low PFC numbers in patients with AS. In unstimulated cultures there were no significant differences in the PFC numbers between the 4 groups ( Fig. 1) . In yersinia-stimulated cultures persons without arthritis had significantly higher PFC numbers than subjects in other groups (NA>C, p<0 001; NA>A, p<0025; NA>AS, p<0 05) (Fig. 1) . In SaCIstimulated cultures persons without arthritis again had significantly higher PFC numbers than subjects in other groups (NA> C, p< 0 001; NA> A, p< 0 05; NA> AS, p< 0-05) ( Table 2 ). The number of PFC in the PWM-stimulated cultures of AS patients was significantly lower than that in persons with or without arthritis (AS<NA, p<005; AS<A, p<005) (Fig. 1) . When the cells were cultured together with PWM and hydrocortisone this difference in the PFC number could no more be detected (data not shown).
When the Ig isotype secretion was measured, the main difference between the 4 groups was found in the IgM production. In unstimulated cultures the A p<0-0125; C p<0-05, paired t test), and there were no more differences in the IgM production between the 4 groups (Fig. 2) . The only difference between the 4 groups in the IgG production was observed in yersinia-stimulated cultures: the IgG production was significantly higher in subjects of the 3 other groups in comparison with controls (NA>C, p<0 05; A>C, p<0-05; AS>C, p<0 05) ( Table 3) .
The production of IgA in PWM-stimulated cultures was on the same level in all groups (Table 3) . Yersinia stimulated IgA production only weakly: in yersinia-stimulated cultures the mean stimulation index (SI = IgA in stimulated culture/IgA in unstimulated culture) was 1-5 and the range was 0-2-5. In unstimulated cultures AS patients had significantly higher IgA production when compared with persons with or without arthritis (AS>NA, p<0-05; AS>A, p<0-05) ( Table 3 ).
All subjects studied were typed for HLA B27 antigen. The differences in the Ig production were not correlated with the presence of this antigen but rather with the clinical history of the subject.
Discussion
The purpose of this study was to compare the in-vitro Ig production in persons who have once had yersinia arthritis and in patients with AS with that in persons who have had yersiniosis without arthritis and with healthy controls without any history of yersiniosis. The main interest was focused primarily on the IgA production because of reports of elevated serum IgA group.bmj.com on April 20, 2017 -Published by http://ard.bmj.com/ Downloaded from in active AS2-5 and higher anti-yersinia IgA in yersinia arthritis.6 7 AS patients showed slightly higher IgA production in unstimulated cultures. However, yersinia did not stimulate IgA production to any significant extent, and in PWM-stimulated cultures there were no differences in the IgA production. This indicates that AS patients and persons who have suffered from yersinia arthritis have no predisposition to a high IgA response in vitro. On the other hand peripheral blood lymphocytes (PBL) may not be the right cells when studying the IgA production in these diseases, since the in vitro response with PWM-stimulated IgA secretion of PBL is more than 90% of the subclass IgA, and less than 10% of the subclass IgA2 (mainly found in vivo in secretions).12 For the IgA2 secretion probably microenvironmental factors, present in the secretory tissues, are needed. In this respect our results may reflect the IgA1 secretion and do not rule out the possibility of an altered immune stimulation or response in the gut in AS and yersinia arthritis.
In the earlier studies we observed that patients with yersinia arthritis have a weaker lymphocyte transformation response to whole yersinia bacteria than patients who recover from yersiniosis without arthritis."3 This depressed response in arthritic patients can be found even years after the acute infection (Vuento et al., unpublished observations). Our present finding of depressed B-lymphocyte activation by yersinia in persons suffered from yersinia arthritis is in accordance with those observed by the lymphocyte transformation test. Depression in both Ig production and blast transformation, notwithstanding that they are distinct phenomena, may indicate an altered immunoregulation in yersinia arthritis. On the other hand elevated yersinia-stimulated IgG production in AS patients suggests that enterobacteria have a role in the causation of AS.
The most striking finding was the low IgM production in vitro in PWM-stimulated cultures from AS patients. When the cells were cultured together with PWM and HC, the IgM production in AS patients normalised. The IgM production, like the IgA and IgG production, showed no correlation with the presence of HLA B27 antigen but rather with the clinical history of the patient. In AS patients serum IgM has been reported to be normal,4 5 but the specific antiklebsiella IgM has been found to be low,"4 as well as the specific anti-yersinia IgM in yersinia arthritis. It is unusual to find that one has read a book from cover to cover, has learned a great deal, has benefited from the authors' success in bringing together the many aspects of the subject, and has enjoyed the clarity and brevity of presentation, while finding little if anything which merits criticism. This volume has satisfied all these points, and the authors are to be congratulated on the undoubted success of their work in producing this comprehensive account of the hypermobility syndrome. As they point out, the hypermobile individual acting as a contortionist has been known since ancient times. However, the scientific and medical implications of hypermobility have been realised and investigated only in the last 50 years and particularly in the last two decades. The present understanding of collagen abnormalities and their association with other conditions are well described. From a practical point of view diagnosis, prevalence, and clinical features are comprehensively and well covered. The 30 pages of clinical accounts of patients with the hypermobility syndrome are most valuable.
This monograph is an essential volume for all rheumatology and orthopaedic libraries and also deserves a place in medical libraries in general in view of the frequency of the syndrome, the overlap with other conditions, and its many and varied manifestations. 
